In addition, the silencing of RFT2 was associated with inhibition of glioma cell proliferation by promoting apoptosis and cell cycle arrest, a reduced invasion and migration, and a decreased tumor growth in vivo [42]. This evidence concerns the gene SLC52A3 and neoplasm.